Merck's Ebola vaccine helps combat deadly outbreak in the Congo as the virus spreads - CNBC

Merck's Ebola vaccine helps combat deadly outbreak in the Congo as the virus spreads  CNBC

An unlicensed vaccine made by Merck was approved for use a week after the DRC declared the Ebola outbreak in August.

View full coverage on Google News